Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intermittent Claudication | 32 | 2021 | 309 | 6.120 |
Why?
|
Cost-Benefit Analysis | 92 | 2023 | 5388 | 3.500 |
Why?
|
Decision Support Techniques | 35 | 2020 | 1956 | 3.050 |
Why?
|
Peripheral Vascular Diseases | 23 | 2009 | 549 | 2.790 |
Why?
|
Exercise Therapy | 15 | 2021 | 904 | 2.430 |
Why?
|
Angiography, Digital Subtraction | 21 | 2014 | 341 | 2.330 |
Why?
|
Markov Chains | 32 | 2022 | 968 | 2.320 |
Why?
|
Quality-Adjusted Life Years | 44 | 2022 | 1683 | 2.320 |
Why?
|
Tomography, X-Ray Computed | 66 | 2022 | 20121 | 2.220 |
Why?
|
Magnetic Resonance Angiography | 23 | 2013 | 1444 | 2.040 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 2 | 2024 | 45 | 1.780 |
Why?
|
Vascular Surgical Procedures | 13 | 2018 | 1476 | 1.640 |
Why?
|
Craniocerebral Trauma | 9 | 2022 | 482 | 1.630 |
Why?
|
Angioplasty, Balloon | 16 | 2013 | 653 | 1.560 |
Why?
|
Quality of Life | 47 | 2022 | 12788 | 1.540 |
Why?
|
Diagnostic Imaging | 15 | 2023 | 3503 | 1.510 |
Why?
|
Coronary Artery Disease | 25 | 2022 | 6485 | 1.450 |
Why?
|
Coronary Angiography | 21 | 2017 | 4576 | 1.450 |
Why?
|
Knee Injuries | 10 | 2011 | 490 | 1.290 |
Why?
|
Ultrasonography, Doppler, Duplex | 11 | 2015 | 205 | 1.250 |
Why?
|
Autopsy | 8 | 2020 | 1020 | 1.200 |
Why?
|
Cardiovascular Diseases | 30 | 2024 | 15142 | 1.200 |
Why?
|
Netherlands | 31 | 2021 | 2170 | 1.120 |
Why?
|
Adenoma | 4 | 2024 | 2173 | 1.110 |
Why?
|
Arterial Occlusive Diseases | 12 | 2005 | 793 | 1.100 |
Why?
|
Chest Pain | 7 | 2016 | 1114 | 1.070 |
Why?
|
Pituitary Neoplasms | 3 | 2023 | 1345 | 1.060 |
Why?
|
Angiography | 12 | 2015 | 1638 | 1.060 |
Why?
|
Health Care Costs | 19 | 2021 | 3207 | 1.030 |
Why?
|
Yoga | 3 | 2018 | 252 | 1.010 |
Why?
|
Asymptomatic Diseases | 4 | 2013 | 552 | 1.010 |
Why?
|
Meditation | 2 | 2018 | 240 | 0.980 |
Why?
|
Uncertainty | 6 | 2012 | 735 | 0.970 |
Why?
|
Coronary Disease | 26 | 2020 | 6078 | 0.960 |
Why?
|
Programming Languages | 3 | 2022 | 133 | 0.910 |
Why?
|
Music Therapy | 4 | 2018 | 102 | 0.890 |
Why?
|
Cardiac Imaging Techniques | 2 | 2017 | 269 | 0.880 |
Why?
|
Primary Prevention | 8 | 2018 | 1167 | 0.830 |
Why?
|
Humans | 317 | 2024 | 743811 | 0.830 |
Why?
|
Mind-Body Therapies | 2 | 2015 | 247 | 0.820 |
Why?
|
Iliac Artery | 8 | 2000 | 364 | 0.800 |
Why?
|
Carotid Stenosis | 8 | 2011 | 854 | 0.800 |
Why?
|
Monte Carlo Method | 13 | 2016 | 1254 | 0.790 |
Why?
|
Sensitivity and Specificity | 47 | 2018 | 14714 | 0.790 |
Why?
|
Acupuncture Therapy | 3 | 2010 | 464 | 0.760 |
Why?
|
Decision Support Systems, Clinical | 4 | 2023 | 1164 | 0.740 |
Why?
|
ROC Curve | 26 | 2018 | 3527 | 0.730 |
Why?
|
Practice Guidelines as Topic | 10 | 2020 | 7270 | 0.720 |
Why?
|
Randomized Controlled Trials as Topic | 17 | 2023 | 9944 | 0.720 |
Why?
|
Myocardial Perfusion Imaging | 4 | 2013 | 555 | 0.720 |
Why?
|
Brain Ischemia | 8 | 2021 | 3264 | 0.710 |
Why?
|
Magnetic Resonance Imaging | 34 | 2020 | 35409 | 0.690 |
Why?
|
Stents | 13 | 2013 | 3280 | 0.670 |
Why?
|
Exercise Test | 13 | 2015 | 2074 | 0.670 |
Why?
|
Breech Presentation | 2 | 2010 | 44 | 0.660 |
Why?
|
Stroke | 16 | 2024 | 9975 | 0.660 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 85 | 0.650 |
Why?
|
Walking | 9 | 2020 | 1182 | 0.650 |
Why?
|
Middle Aged | 149 | 2021 | 213241 | 0.650 |
Why?
|
Popliteal Artery | 8 | 2013 | 317 | 0.650 |
Why?
|
Computer Simulation | 17 | 2020 | 6188 | 0.640 |
Why?
|
Leg | 12 | 2011 | 1116 | 0.640 |
Why?
|
Aged | 134 | 2021 | 163178 | 0.630 |
Why?
|
Musculoskeletal Diseases | 2 | 2017 | 581 | 0.620 |
Why?
|
Renal Artery Obstruction | 4 | 2007 | 248 | 0.620 |
Why?
|
Models, Statistical | 17 | 2020 | 5100 | 0.610 |
Why?
|
Risk Reduction Behavior | 4 | 2019 | 1125 | 0.610 |
Why?
|
Lymphoma, Follicular | 1 | 2021 | 435 | 0.600 |
Why?
|
Renal Replacement Therapy | 2 | 2011 | 258 | 0.600 |
Why?
|
Ultrasonography, Doppler, Color | 4 | 2003 | 233 | 0.600 |
Why?
|
Male | 171 | 2021 | 349776 | 0.590 |
Why?
|
Glasgow Coma Scale | 8 | 2022 | 570 | 0.580 |
Why?
|
Decision Making | 13 | 2018 | 3887 | 0.580 |
Why?
|
Predictive Value of Tests | 36 | 2017 | 15067 | 0.570 |
Why?
|
Living Donors | 4 | 2011 | 621 | 0.570 |
Why?
|
Female | 171 | 2020 | 380020 | 0.570 |
Why?
|
Evidence-Based Medicine | 8 | 2020 | 3608 | 0.570 |
Why?
|
Resilience, Psychological | 1 | 2023 | 677 | 0.550 |
Why?
|
Hyperthermia, Induced | 1 | 2019 | 404 | 0.520 |
Why?
|
Risk Assessment | 35 | 2022 | 23327 | 0.510 |
Why?
|
Peripheral Arterial Disease | 5 | 2015 | 1188 | 0.510 |
Why?
|
Models, Economic | 9 | 2020 | 712 | 0.500 |
Why?
|
Life Style | 4 | 2019 | 3833 | 0.500 |
Why?
|
Patient Selection | 14 | 2018 | 4210 | 0.490 |
Why?
|
Occupational Health Services | 1 | 2015 | 154 | 0.480 |
Why?
|
Ischemic Attack, Transient | 4 | 2011 | 934 | 0.480 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2013 | 1187 | 0.470 |
Why?
|
Femoral Artery | 7 | 2004 | 845 | 0.470 |
Why?
|
Guidelines as Topic | 2 | 2019 | 1404 | 0.470 |
Why?
|
Endovascular Procedures | 10 | 2019 | 1980 | 0.470 |
Why?
|
Chi-Square Distribution | 13 | 2015 | 3503 | 0.470 |
Why?
|
Natural Language Processing | 2 | 2019 | 1041 | 0.450 |
Why?
|
Health Status | 10 | 2018 | 4031 | 0.450 |
Why?
|
Technology Assessment, Biomedical | 3 | 2021 | 306 | 0.450 |
Why?
|
Decision Trees | 11 | 2021 | 506 | 0.450 |
Why?
|
Treatment Outcome | 48 | 2021 | 63042 | 0.450 |
Why?
|
Risk Factors | 63 | 2023 | 72252 | 0.450 |
Why?
|
Costs and Cost Analysis | 12 | 2012 | 1680 | 0.450 |
Why?
|
Mass Screening | 7 | 2016 | 5251 | 0.440 |
Why?
|
Gynecological Examination | 1 | 2013 | 33 | 0.440 |
Why?
|
Echocardiography, Stress | 4 | 2011 | 131 | 0.440 |
Why?
|
Calcium | 6 | 2022 | 5755 | 0.440 |
Why?
|
Attitude to Health | 6 | 2000 | 2052 | 0.440 |
Why?
|
Peritoneal Neoplasms | 1 | 2019 | 665 | 0.430 |
Why?
|
Wrist Injuries | 2 | 2005 | 208 | 0.430 |
Why?
|
Perfusion Imaging | 1 | 2014 | 195 | 0.430 |
Why?
|
Brain Injuries | 6 | 2019 | 2029 | 0.430 |
Why?
|
Life Expectancy | 6 | 2014 | 1184 | 0.420 |
Why?
|
Ischemia | 10 | 2017 | 1907 | 0.420 |
Why?
|
Endarterectomy, Carotid | 5 | 2011 | 546 | 0.420 |
Why?
|
Coronary Stenosis | 6 | 2017 | 833 | 0.420 |
Why?
|
Cerebral Angiography | 3 | 2014 | 1285 | 0.420 |
Why?
|
Aged, 80 and over | 58 | 2022 | 57744 | 0.420 |
Why?
|
Vasospasm, Intracranial | 1 | 2014 | 208 | 0.410 |
Why?
|
Radiology | 9 | 2018 | 2099 | 0.410 |
Why?
|
Radiography | 10 | 2023 | 7010 | 0.410 |
Why?
|
Calcinosis | 7 | 2011 | 1495 | 0.400 |
Why?
|
Prospective Studies | 47 | 2022 | 53250 | 0.400 |
Why?
|
Kidney Transplantation | 6 | 2011 | 4251 | 0.400 |
Why?
|
Angioplasty | 4 | 2014 | 364 | 0.390 |
Why?
|
Ankle Injuries | 3 | 2006 | 331 | 0.390 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2014 | 266 | 0.390 |
Why?
|
Emergency Service, Hospital | 5 | 2021 | 7658 | 0.390 |
Why?
|
Coronary Vessels | 5 | 2022 | 3106 | 0.380 |
Why?
|
Amygdala | 1 | 2018 | 1313 | 0.380 |
Why?
|
Adult | 90 | 2024 | 213889 | 0.380 |
Why?
|
Aortic Rupture | 5 | 2011 | 312 | 0.380 |
Why?
|
Carotid Artery Diseases | 5 | 2011 | 875 | 0.380 |
Why?
|
Hospital Costs | 5 | 2013 | 985 | 0.370 |
Why?
|
Angina Pectoris | 3 | 2011 | 977 | 0.360 |
Why?
|
Cause of Death | 10 | 2020 | 3580 | 0.360 |
Why?
|
Logistic Models | 18 | 2017 | 13404 | 0.350 |
Why?
|
Health Status Indicators | 5 | 2000 | 970 | 0.350 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 2009 | 58 | 0.350 |
Why?
|
Peritoneal Dialysis | 2 | 2007 | 147 | 0.350 |
Why?
|
Statistics, Nonparametric | 8 | 2013 | 2883 | 0.350 |
Why?
|
Reproducibility of Results | 28 | 2019 | 19894 | 0.350 |
Why?
|
Pain Measurement | 4 | 2018 | 3420 | 0.350 |
Why?
|
Family Practice | 2 | 2009 | 516 | 0.350 |
Why?
|
Regression Analysis | 17 | 2016 | 6457 | 0.350 |
Why?
|
Mastectomy | 1 | 2017 | 1793 | 0.340 |
Why?
|
Subarachnoid Hemorrhage | 3 | 2014 | 1018 | 0.340 |
Why?
|
Ankle Brachial Index | 4 | 2014 | 154 | 0.330 |
Why?
|
Models, Theoretical | 8 | 2017 | 3587 | 0.330 |
Why?
|
Physical Endurance | 1 | 2011 | 370 | 0.330 |
Why?
|
Meta-Analysis as Topic | 6 | 2023 | 1340 | 0.330 |
Why?
|
Mobility Limitation | 2 | 2011 | 409 | 0.330 |
Why?
|
Contrast Media | 13 | 2018 | 5301 | 0.330 |
Why?
|
Menstruation Disturbances | 1 | 2009 | 148 | 0.330 |
Why?
|
Hypercholesterolemia | 4 | 2012 | 1151 | 0.320 |
Why?
|
Otolaryngology | 3 | 2020 | 643 | 0.320 |
Why?
|
Aortic Diseases | 5 | 2011 | 743 | 0.310 |
Why?
|
Secondary Prevention | 1 | 2014 | 1529 | 0.310 |
Why?
|
Triglycerides | 1 | 2015 | 2453 | 0.300 |
Why?
|
Vascular Patency | 9 | 2014 | 887 | 0.300 |
Why?
|
Mammaplasty | 1 | 2017 | 1204 | 0.300 |
Why?
|
Severity of Illness Index | 19 | 2019 | 15526 | 0.300 |
Why?
|
Head Injuries, Closed | 3 | 2019 | 139 | 0.300 |
Why?
|
Kidney Failure, Chronic | 3 | 2011 | 2534 | 0.290 |
Why?
|
Sex Factors | 17 | 2018 | 10394 | 0.290 |
Why?
|
Blood Vessel Prosthesis Implantation | 5 | 2015 | 1391 | 0.290 |
Why?
|
Aneurysm | 3 | 2015 | 339 | 0.290 |
Why?
|
Thrombectomy | 3 | 2021 | 680 | 0.290 |
Why?
|
Stress, Psychological | 6 | 2018 | 4245 | 0.290 |
Why?
|
Health Promotion | 2 | 2018 | 2205 | 0.290 |
Why?
|
Blood Platelet Disorders | 1 | 2007 | 59 | 0.290 |
Why?
|
Follow-Up Studies | 24 | 2021 | 39001 | 0.290 |
Why?
|
Software | 6 | 2022 | 4440 | 0.280 |
Why?
|
Prognosis | 18 | 2019 | 29052 | 0.280 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2020 | 3255 | 0.280 |
Why?
|
Time Factors | 29 | 2021 | 40038 | 0.280 |
Why?
|
Biopsy | 3 | 2015 | 6750 | 0.280 |
Why?
|
Prostate | 1 | 2014 | 1763 | 0.280 |
Why?
|
Menstrual Cycle | 1 | 2009 | 551 | 0.270 |
Why?
|
Heart Diseases | 3 | 2015 | 2789 | 0.270 |
Why?
|
Amaurosis Fugax | 1 | 2005 | 7 | 0.270 |
Why?
|
Platelet Function Tests | 1 | 2007 | 270 | 0.270 |
Why?
|
Wounds, Nonpenetrating | 2 | 2007 | 795 | 0.270 |
Why?
|
Recovery of Function | 8 | 2014 | 2922 | 0.260 |
Why?
|
Myocardial Ischemia | 3 | 2018 | 2150 | 0.260 |
Why?
|
Defibrillators, Implantable | 2 | 2012 | 1439 | 0.260 |
Why?
|
Algorithms | 8 | 2019 | 13869 | 0.260 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2018 | 2018 | 0.250 |
Why?
|
Cohort Studies | 20 | 2022 | 40545 | 0.250 |
Why?
|
Resource Allocation | 2 | 2018 | 341 | 0.250 |
Why?
|
Radiosurgery | 1 | 2014 | 1331 | 0.250 |
Why?
|
Patient Satisfaction | 2 | 2010 | 3391 | 0.250 |
Why?
|
Splenic Artery | 2 | 2015 | 54 | 0.250 |
Why?
|
Death, Sudden, Cardiac | 2 | 2012 | 1542 | 0.250 |
Why?
|
Body Mass Index | 6 | 2015 | 12718 | 0.240 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 6 | 2016 | 1108 | 0.240 |
Why?
|
Specialties, Surgical | 1 | 2009 | 391 | 0.240 |
Why?
|
Colorectal Neoplasms | 5 | 2019 | 6773 | 0.240 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1676 | 0.230 |
Why?
|
Gadolinium DTPA | 3 | 2018 | 836 | 0.230 |
Why?
|
Blood Glucose | 2 | 2015 | 6259 | 0.230 |
Why?
|
Forecasting | 1 | 2012 | 2950 | 0.230 |
Why?
|
Lactotrophs | 1 | 2022 | 3 | 0.230 |
Why?
|
Somatotrophs | 1 | 2022 | 2 | 0.230 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5319 | 0.220 |
Why?
|
Cost of Illness | 5 | 2012 | 1859 | 0.220 |
Why?
|
Kidney | 5 | 2017 | 7185 | 0.220 |
Why?
|
Probability | 7 | 2022 | 2505 | 0.210 |
Why?
|
Amnesia | 2 | 2019 | 248 | 0.210 |
Why?
|
Atherosclerosis | 5 | 2022 | 3445 | 0.210 |
Why?
|
Comparative Effectiveness Research | 4 | 2016 | 680 | 0.200 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 5752 | 0.200 |
Why?
|
Octreotide | 1 | 2022 | 146 | 0.200 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2012 | 1537 | 0.200 |
Why?
|
Mitral Valve Insufficiency | 1 | 2011 | 1421 | 0.200 |
Why?
|
Neoplasm Staging | 3 | 2014 | 11036 | 0.200 |
Why?
|
Radiology, Interventional | 1 | 2005 | 460 | 0.200 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8637 | 0.190 |
Why?
|
Genes, BRCA1 | 2 | 2016 | 781 | 0.190 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2074 | 0.190 |
Why?
|
Cost Savings | 5 | 2016 | 925 | 0.190 |
Why?
|
Proportional Hazards Models | 12 | 2024 | 12354 | 0.190 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 1994 | 277 | 0.190 |
Why?
|
Prevalence | 13 | 2017 | 15211 | 0.190 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2021 | 397 | 0.180 |
Why?
|
Ritonavir | 1 | 2022 | 322 | 0.180 |
Why?
|
Intention | 1 | 2023 | 341 | 0.180 |
Why?
|
Triage | 2 | 2019 | 977 | 0.180 |
Why?
|
Canada | 2 | 2021 | 2064 | 0.180 |
Why?
|
Selection Bias | 1 | 2002 | 371 | 0.180 |
Why?
|
Aortic Valve Stenosis | 1 | 2012 | 1955 | 0.180 |
Why?
|
Mastectomy, Segmental | 2 | 2017 | 956 | 0.180 |
Why?
|
Positron-Emission Tomography | 4 | 2016 | 6237 | 0.180 |
Why?
|
Research Design | 5 | 2023 | 5983 | 0.180 |
Why?
|
Confidence Intervals | 5 | 2012 | 2971 | 0.170 |
Why?
|
Abdominal Neoplasms | 1 | 2001 | 292 | 0.170 |
Why?
|
Lower Extremity | 1 | 2007 | 1158 | 0.170 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2337 | 0.170 |
Why?
|
Odds Ratio | 10 | 2015 | 9848 | 0.170 |
Why?
|
Dyslipidemias | 2 | 2017 | 851 | 0.170 |
Why?
|
Aorta, Thoracic | 6 | 2014 | 1084 | 0.170 |
Why?
|
Life Tables | 5 | 1998 | 363 | 0.170 |
Why?
|
Radiography, Interventional | 4 | 2018 | 1095 | 0.170 |
Why?
|
Gadolinium | 2 | 2003 | 950 | 0.170 |
Why?
|
Synovitis | 1 | 2020 | 209 | 0.170 |
Why?
|
Breast Neoplasms | 5 | 2017 | 20827 | 0.170 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2018 | 32 | 0.160 |
Why?
|
Adenoma, Liver Cell | 1 | 2018 | 33 | 0.160 |
Why?
|
Thoracic Injuries | 2 | 2005 | 272 | 0.160 |
Why?
|
Adolescent | 26 | 2022 | 85729 | 0.160 |
Why?
|
Hormones | 1 | 2022 | 889 | 0.160 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 412 | 0.160 |
Why?
|
Creatinine | 3 | 2024 | 1918 | 0.160 |
Why?
|
Meglumine | 1 | 2018 | 149 | 0.160 |
Why?
|
Hospital Mortality | 5 | 2018 | 5316 | 0.160 |
Why?
|
United States | 27 | 2022 | 69859 | 0.160 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2016 | 3070 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.160 |
Why?
|
Arteriosclerosis | 4 | 2008 | 1092 | 0.160 |
Why?
|
Directive Counseling | 1 | 2019 | 166 | 0.150 |
Why?
|
Postoperative Period | 1 | 2023 | 1841 | 0.150 |
Why?
|
Vascular Diseases | 3 | 2014 | 1161 | 0.150 |
Why?
|
Interviews as Topic | 2 | 2010 | 2538 | 0.150 |
Why?
|
Endosonography | 2 | 2014 | 610 | 0.150 |
Why?
|
Postmortem Changes | 1 | 2017 | 124 | 0.150 |
Why?
|
Data Interpretation, Statistical | 4 | 2023 | 2715 | 0.150 |
Why?
|
Ultrasonography, Prenatal | 2 | 2020 | 1695 | 0.150 |
Why?
|
Age Factors | 13 | 2018 | 18355 | 0.150 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2014 | 691 | 0.150 |
Why?
|
Anxiety | 3 | 2018 | 4288 | 0.150 |
Why?
|
Surgical Procedures, Operative | 1 | 2009 | 1877 | 0.150 |
Why?
|
Nephrectomy | 3 | 2017 | 1048 | 0.150 |
Why?
|
Post-Concussion Syndrome | 2 | 2010 | 219 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2018 | 4251 | 0.150 |
Why?
|
Survival Rate | 6 | 2019 | 12786 | 0.150 |
Why?
|
Survival Analysis | 6 | 2012 | 10251 | 0.150 |
Why?
|
Salvage Therapy | 1 | 2024 | 1275 | 0.150 |
Why?
|
Forensic Medicine | 1 | 2017 | 64 | 0.150 |
Why?
|
Myocardial Infarction | 7 | 2018 | 11708 | 0.150 |
Why?
|
Internet | 4 | 2019 | 3058 | 0.150 |
Why?
|
Mammography | 3 | 2017 | 2475 | 0.150 |
Why?
|
Universities | 1 | 2022 | 951 | 0.150 |
Why?
|
Models, Biological | 2 | 2012 | 9582 | 0.150 |
Why?
|
Organometallic Compounds | 2 | 2018 | 665 | 0.140 |
Why?
|
Standard of Care | 3 | 2019 | 564 | 0.140 |
Why?
|
False Positive Reactions | 5 | 2007 | 980 | 0.140 |
Why?
|
Glucose Metabolism Disorders | 1 | 2016 | 54 | 0.140 |
Why?
|
Wounds and Injuries | 2 | 2008 | 2401 | 0.140 |
Why?
|
Area Under Curve | 4 | 2018 | 1654 | 0.140 |
Why?
|
Veins | 1 | 2001 | 770 | 0.140 |
Why?
|
Hypertension | 7 | 2017 | 8480 | 0.140 |
Why?
|
Blood Flow Velocity | 6 | 2013 | 1423 | 0.140 |
Why?
|
Hernia, Ventral | 1 | 2019 | 176 | 0.140 |
Why?
|
Osteoarthritis, Knee | 2 | 2020 | 1222 | 0.140 |
Why?
|
Contusions | 2 | 2007 | 81 | 0.140 |
Why?
|
Catheterization | 1 | 2001 | 1469 | 0.140 |
Why?
|
Catheter Ablation | 1 | 2009 | 2758 | 0.140 |
Why?
|
Longitudinal Studies | 7 | 2018 | 13980 | 0.130 |
Why?
|
Aorta, Abdominal | 3 | 1997 | 646 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5230 | 0.130 |
Why?
|
Age Distribution | 4 | 2011 | 2899 | 0.130 |
Why?
|
Intracranial Hemorrhage, Traumatic | 1 | 2016 | 54 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 828 | 0.130 |
Why?
|
Vasodilator Agents | 3 | 2018 | 974 | 0.130 |
Why?
|
Observer Variation | 6 | 2018 | 2592 | 0.130 |
Why?
|
Echocardiography | 4 | 2015 | 5096 | 0.130 |
Why?
|
Treatment Failure | 2 | 2009 | 2617 | 0.130 |
Why?
|
Popliteal Vein | 1 | 1995 | 43 | 0.130 |
Why?
|
Young Adult | 19 | 2019 | 56392 | 0.130 |
Why?
|
Liver Cirrhosis | 2 | 2016 | 1859 | 0.130 |
Why?
|
Kidney Diseases, Cystic | 1 | 2017 | 186 | 0.130 |
Why?
|
Tissue Donors | 2 | 2016 | 2241 | 0.130 |
Why?
|
Radiography, Thoracic | 2 | 2019 | 1265 | 0.130 |
Why?
|
Sick Leave | 1 | 2016 | 110 | 0.130 |
Why?
|
Smoking | 7 | 2017 | 8984 | 0.130 |
Why?
|
Smoking Cessation | 2 | 2018 | 2071 | 0.130 |
Why?
|
Telephone | 1 | 1998 | 617 | 0.130 |
Why?
|
Ultrasonography, Mammary | 1 | 2017 | 250 | 0.130 |
Why?
|
Health Care Rationing | 1 | 1998 | 437 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2012 | 851 | 0.130 |
Why?
|
Cholesterol, LDL | 3 | 2015 | 2354 | 0.130 |
Why?
|
Mental Health | 2 | 2022 | 3012 | 0.130 |
Why?
|
Dexamethasone | 1 | 2022 | 1950 | 0.120 |
Why?
|
Femoral Vein | 1 | 1995 | 159 | 0.120 |
Why?
|
Musculoskeletal System | 1 | 2017 | 175 | 0.120 |
Why?
|
Sweden | 1 | 2017 | 1341 | 0.120 |
Why?
|
Watchful Waiting | 1 | 2019 | 491 | 0.120 |
Why?
|
Retirement | 1 | 2016 | 216 | 0.120 |
Why?
|
Europe | 4 | 2016 | 3336 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2014 | 13112 | 0.120 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 426 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9239 | 0.120 |
Why?
|
Unconsciousness | 3 | 2019 | 263 | 0.120 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2015 | 114 | 0.120 |
Why?
|
Nutrition Policy | 1 | 2018 | 488 | 0.120 |
Why?
|
Saphenous Vein | 2 | 2013 | 532 | 0.120 |
Why?
|
Blood Vessel Prosthesis | 3 | 2007 | 933 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 2 | 2016 | 388 | 0.120 |
Why?
|
Retrospective Studies | 19 | 2022 | 77410 | 0.120 |
Why?
|
Tumor Burden | 2 | 2017 | 1917 | 0.120 |
Why?
|
Referral and Consultation | 3 | 2016 | 3530 | 0.120 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1377 | 0.120 |
Why?
|
Ticlopidine | 2 | 2014 | 899 | 0.120 |
Why?
|
Analysis of Variance | 4 | 2008 | 6356 | 0.120 |
Why?
|
False Negative Reactions | 3 | 2003 | 588 | 0.110 |
Why?
|
Organ Size | 1 | 2018 | 2241 | 0.110 |
Why?
|
Carotid Arteries | 2 | 2010 | 949 | 0.110 |
Why?
|
Functional Laterality | 2 | 2018 | 2280 | 0.110 |
Why?
|
Peritoneal Diseases | 1 | 2014 | 75 | 0.110 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2739 | 0.110 |
Why?
|
Biomedical Research | 3 | 2018 | 3308 | 0.110 |
Why?
|
Pain | 3 | 2015 | 4987 | 0.110 |
Why?
|
Fetus | 1 | 2020 | 1880 | 0.110 |
Why?
|
Clinical Trials as Topic | 5 | 2012 | 7908 | 0.110 |
Why?
|
Students | 1 | 2022 | 1647 | 0.110 |
Why?
|
Ovarian Diseases | 1 | 2014 | 139 | 0.110 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2014 | 292 | 0.110 |
Why?
|
Antihypertensive Agents | 2 | 2017 | 2047 | 0.110 |
Why?
|
Tetrazoles | 1 | 2018 | 834 | 0.110 |
Why?
|
Acute Disease | 5 | 2019 | 7150 | 0.110 |
Why?
|
Nutrition Surveys | 2 | 2022 | 1660 | 0.100 |
Why?
|
Heart Rate | 5 | 2015 | 4091 | 0.100 |
Why?
|
Resistance Training | 1 | 2014 | 164 | 0.100 |
Why?
|
Blood Pressure | 7 | 2019 | 8551 | 0.100 |
Why?
|
Risk | 3 | 2014 | 9677 | 0.100 |
Why?
|
Cadaver | 2 | 2018 | 1335 | 0.100 |
Why?
|
Scalp | 1 | 2015 | 378 | 0.100 |
Why?
|
Brain | 3 | 2016 | 26345 | 0.100 |
Why?
|
Single-Blind Method | 3 | 2018 | 1586 | 0.100 |
Why?
|
Review Literature as Topic | 1 | 2014 | 336 | 0.100 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 11059 | 0.100 |
Why?
|
Anastomosis, Surgical | 1 | 1995 | 987 | 0.100 |
Why?
|
Cholesterol, HDL | 3 | 2015 | 1813 | 0.100 |
Why?
|
Models, Econometric | 3 | 2008 | 218 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2001 | 2288 | 0.100 |
Why?
|
Hair | 1 | 2015 | 480 | 0.100 |
Why?
|
Research Support as Topic | 1 | 1996 | 705 | 0.100 |
Why?
|
Reperfusion | 3 | 2020 | 283 | 0.100 |
Why?
|
Cross-Sectional Studies | 6 | 2018 | 25032 | 0.100 |
Why?
|
Radiology Information Systems | 1 | 2016 | 523 | 0.100 |
Why?
|
Psychotherapy, Group | 1 | 2015 | 407 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 516 | 0.100 |
Why?
|
Occupational Health | 1 | 2018 | 808 | 0.100 |
Why?
|
Authorship | 1 | 2014 | 271 | 0.100 |
Why?
|
Disease Progression | 6 | 2018 | 13273 | 0.090 |
Why?
|
Thrombolytic Therapy | 2 | 2019 | 2162 | 0.090 |
Why?
|
Exercise | 2 | 2018 | 5611 | 0.090 |
Why?
|
Survival | 1 | 2011 | 163 | 0.090 |
Why?
|
Cystic Fibrosis | 1 | 2019 | 1178 | 0.090 |
Why?
|
Disease-Free Survival | 4 | 2013 | 6895 | 0.090 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 1990 | 234 | 0.090 |
Why?
|
Multivariate Analysis | 6 | 2015 | 12243 | 0.090 |
Why?
|
Moxibustion | 1 | 2010 | 8 | 0.090 |
Why?
|
Employment | 2 | 2016 | 1132 | 0.090 |
Why?
|
DNA Fingerprinting | 1 | 2010 | 112 | 0.090 |
Why?
|
Drug Costs | 2 | 2017 | 1105 | 0.090 |
Why?
|
Postoperative Complications | 7 | 2015 | 15281 | 0.090 |
Why?
|
Acupuncture Points | 1 | 2010 | 101 | 0.090 |
Why?
|
Pharmacogenetics | 1 | 2014 | 674 | 0.090 |
Why?
|
Version, Fetal | 1 | 2010 | 25 | 0.090 |
Why?
|
Hospitalization | 3 | 2019 | 10259 | 0.090 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2012 | 197 | 0.090 |
Why?
|
Chronic Disease | 3 | 2018 | 9139 | 0.090 |
Why?
|
Early Diagnosis | 2 | 2011 | 1186 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2014 | 768 | 0.090 |
Why?
|
Stochastic Processes | 1 | 2010 | 344 | 0.090 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2013 | 289 | 0.090 |
Why?
|
Information Dissemination | 1 | 2018 | 1099 | 0.090 |
Why?
|
Diffuse Axonal Injury | 1 | 2009 | 49 | 0.090 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 592 | 0.090 |
Why?
|
Body Constitution | 1 | 2009 | 278 | 0.090 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 700 | 0.090 |
Why?
|
Health Surveys | 4 | 2016 | 4036 | 0.080 |
Why?
|
Heart Failure | 3 | 2023 | 10896 | 0.080 |
Why?
|
Renal Veins | 2 | 2008 | 108 | 0.080 |
Why?
|
Electrocardiography | 4 | 2015 | 6441 | 0.080 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2013 | 1184 | 0.080 |
Why?
|
Graft Occlusion, Vascular | 2 | 2007 | 549 | 0.080 |
Why?
|
Skull Fractures | 2 | 2007 | 195 | 0.080 |
Why?
|
Reoperation | 6 | 2014 | 4200 | 0.080 |
Why?
|
Hospitals, University | 2 | 2005 | 570 | 0.080 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1990 | 214 | 0.080 |
Why?
|
Incidence | 10 | 2021 | 20948 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 11729 | 0.080 |
Why?
|
Midwifery | 1 | 2010 | 132 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 855 | 0.080 |
Why?
|
Cerebrovascular Disorders | 2 | 2014 | 1504 | 0.080 |
Why?
|
Activities of Daily Living | 2 | 2013 | 2419 | 0.080 |
Why?
|
Breast | 1 | 2017 | 1970 | 0.080 |
Why?
|
Aneurysm, Ruptured | 2 | 2014 | 452 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1642 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2575 | 0.080 |
Why?
|
MEDLINE | 1 | 2007 | 125 | 0.080 |
Why?
|
Nose Neoplasms | 1 | 1990 | 246 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 8939 | 0.080 |
Why?
|
Nasolacrimal Duct | 1 | 1988 | 74 | 0.080 |
Why?
|
Cardiovascular Agents | 2 | 2013 | 850 | 0.070 |
Why?
|
Comorbidity | 6 | 2017 | 10380 | 0.070 |
Why?
|
Injury Severity Score | 2 | 2007 | 1014 | 0.070 |
Why?
|
Counseling | 1 | 2015 | 1523 | 0.070 |
Why?
|
Communication | 1 | 2001 | 3748 | 0.070 |
Why?
|
Heterozygote | 1 | 2014 | 2803 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2019 | 1917 | 0.070 |
Why?
|
Renal Artery | 2 | 2008 | 399 | 0.070 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1990 | 287 | 0.070 |
Why?
|
Infant, Premature | 1 | 2016 | 2031 | 0.070 |
Why?
|
Carcinoma in Situ | 1 | 2013 | 805 | 0.070 |
Why?
|
Hydrocortisone | 1 | 2015 | 1826 | 0.070 |
Why?
|
Lung | 2 | 2019 | 9858 | 0.070 |
Why?
|
Knee | 1 | 2008 | 273 | 0.070 |
Why?
|
Metagenomics | 1 | 2010 | 428 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 1861 | 0.070 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.070 |
Why?
|
Brachial Artery | 1 | 2008 | 369 | 0.070 |
Why?
|
Publishing | 1 | 2014 | 833 | 0.070 |
Why?
|
Databases, Factual | 3 | 2018 | 7729 | 0.070 |
Why?
|
Burns | 1 | 2018 | 1815 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2014 | 1415 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 2014 | 1063 | 0.070 |
Why?
|
Value of Life | 2 | 2004 | 97 | 0.070 |
Why?
|
Collateral Ligaments | 1 | 2006 | 34 | 0.070 |
Why?
|
Ultrasonography, Doppler | 2 | 2020 | 458 | 0.070 |
Why?
|
Hippocampus | 1 | 2018 | 3672 | 0.070 |
Why?
|
Lacrimal Apparatus | 1 | 1988 | 225 | 0.070 |
Why?
|
Health Behavior | 2 | 2015 | 2634 | 0.070 |
Why?
|
Professional Competence | 1 | 2009 | 447 | 0.070 |
Why?
|
Endometriosis | 1 | 2014 | 838 | 0.070 |
Why?
|
Sickness Impact Profile | 1 | 2007 | 302 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5445 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 640 | 0.070 |
Why?
|
Health | 1 | 2008 | 394 | 0.070 |
Why?
|
Propensity Score | 1 | 2012 | 1781 | 0.070 |
Why?
|
Paranasal Sinuses | 1 | 1988 | 250 | 0.070 |
Why?
|
Bone and Bones | 2 | 2007 | 2576 | 0.070 |
Why?
|
Liver | 2 | 2018 | 7479 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2012 | 2712 | 0.070 |
Why?
|
Motivation | 1 | 2015 | 1971 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1572 | 0.070 |
Why?
|
Immunization Programs | 1 | 2008 | 260 | 0.060 |
Why?
|
Ankle | 1 | 2008 | 327 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2013 | 6539 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 500 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2013 | 1100 | 0.060 |
Why?
|
Colonoscopy | 2 | 2010 | 1367 | 0.060 |
Why?
|
Colonic Polyps | 1 | 2010 | 542 | 0.060 |
Why?
|
Publication Bias | 2 | 2016 | 162 | 0.060 |
Why?
|
Coronary Restenosis | 1 | 2007 | 424 | 0.060 |
Why?
|
Iohexol | 1 | 2005 | 196 | 0.060 |
Why?
|
Length of Stay | 3 | 2009 | 6311 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2010 | 531 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2010 | 957 | 0.060 |
Why?
|
Tibial Fractures | 1 | 2007 | 269 | 0.060 |
Why?
|
Hemostasis | 1 | 2007 | 458 | 0.060 |
Why?
|
Linear Models | 3 | 2006 | 5952 | 0.060 |
Why?
|
Gynecology | 1 | 2010 | 512 | 0.060 |
Why?
|
Ambulatory Care Facilities | 1 | 2010 | 934 | 0.060 |
Why?
|
Aortography | 3 | 2009 | 437 | 0.060 |
Why?
|
Cholesterol | 3 | 2014 | 2922 | 0.060 |
Why?
|
Femoral Fractures | 1 | 2007 | 376 | 0.060 |
Why?
|
Ultrasonography | 4 | 2020 | 5986 | 0.060 |
Why?
|
Systole | 1 | 2005 | 958 | 0.060 |
Why?
|
Societies, Scientific | 1 | 2004 | 220 | 0.060 |
Why?
|
Affect | 1 | 2011 | 1473 | 0.060 |
Why?
|
Critical Care | 1 | 2016 | 2647 | 0.050 |
Why?
|
Hospitals, Community | 1 | 2005 | 347 | 0.050 |
Why?
|
Policy Making | 1 | 2007 | 554 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3758 | 0.050 |
Why?
|
Memory Disorders | 1 | 2009 | 1186 | 0.050 |
Why?
|
Academic Medical Centers | 3 | 2018 | 2760 | 0.050 |
Why?
|
Stroke Volume | 2 | 2012 | 5002 | 0.050 |
Why?
|
Consensus | 1 | 2011 | 2954 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2009 | 1828 | 0.050 |
Why?
|
Hemodynamics | 3 | 2006 | 4197 | 0.050 |
Why?
|
Anesthesia | 1 | 2013 | 1562 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3307 | 0.050 |
Why?
|
Logic | 1 | 2001 | 39 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2005 | 633 | 0.050 |
Why?
|
Intracranial Embolism | 1 | 2003 | 202 | 0.050 |
Why?
|
Health Education | 2 | 1999 | 1056 | 0.050 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 2877 | 0.050 |
Why?
|
Cesarean Section | 1 | 2010 | 1365 | 0.050 |
Why?
|
Albumins | 1 | 2024 | 568 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5096 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2007 | 1459 | 0.050 |
Why?
|
Anticoagulants | 1 | 2016 | 4599 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2009 | 1017 | 0.050 |
Why?
|
Graft Survival | 1 | 2011 | 3734 | 0.050 |
Why?
|
Pregnancy | 3 | 2020 | 29140 | 0.050 |
Why?
|
Neurosurgical Procedures | 2 | 2008 | 2002 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4260 | 0.050 |
Why?
|
Food, Fortified | 1 | 2001 | 191 | 0.040 |
Why?
|
Epidemiologic Methods | 2 | 2020 | 1364 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12944 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1392 | 0.040 |
Why?
|
Hepatectomy | 1 | 2003 | 550 | 0.040 |
Why?
|
Reference Standards | 2 | 2018 | 1023 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 3 | 2014 | 4033 | 0.040 |
Why?
|
Patient Compliance | 1 | 2010 | 2683 | 0.040 |
Why?
|
Child, Preschool | 3 | 2018 | 40964 | 0.040 |
Why?
|
Educational Status | 3 | 2019 | 2540 | 0.040 |
Why?
|
Intracranial Aneurysm | 1 | 2008 | 1197 | 0.040 |
Why?
|
Sex Distribution | 3 | 2010 | 2298 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2016 | 0.040 |
Why?
|
Registries | 3 | 2015 | 8090 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2010 | 2647 | 0.040 |
Why?
|
Cervical Vertebrae | 1 | 2005 | 976 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2023 | 2123 | 0.040 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2019 | 90 | 0.040 |
Why?
|
Spinal Fractures | 1 | 2005 | 696 | 0.040 |
Why?
|
Hospitals, Special | 1 | 2019 | 101 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2001 | 527 | 0.040 |
Why?
|
Brain Diseases | 1 | 2007 | 1558 | 0.040 |
Why?
|
Thinking | 1 | 2001 | 317 | 0.040 |
Why?
|
Simvastatin | 2 | 2017 | 360 | 0.040 |
Why?
|
Homocysteine | 1 | 2001 | 647 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2003 | 1011 | 0.040 |
Why?
|
Intracranial Thrombosis | 1 | 2019 | 113 | 0.040 |
Why?
|
Patient Simulation | 1 | 2000 | 309 | 0.040 |
Why?
|
Diet | 1 | 2016 | 7930 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2008 | 1585 | 0.040 |
Why?
|
Transportation of Patients | 1 | 2019 | 185 | 0.040 |
Why?
|
Catheterization, Peripheral | 1 | 2001 | 345 | 0.040 |
Why?
|
Electronic Mail | 1 | 2019 | 213 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2006 | 1783 | 0.040 |
Why?
|
Random Allocation | 1 | 2002 | 2429 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2007 | 1619 | 0.040 |
Why?
|
Myocardial Revascularization | 2 | 2012 | 841 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2013 | 4584 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2002 | 725 | 0.040 |
Why?
|
Amlodipine | 1 | 2017 | 83 | 0.040 |
Why?
|
Hydrochlorothiazide | 1 | 2017 | 98 | 0.040 |
Why?
|
Calibration | 2 | 2011 | 816 | 0.040 |
Why?
|
Tablets | 1 | 2017 | 145 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1360 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2003 | 1195 | 0.040 |
Why?
|
Third-Party Consent | 1 | 2016 | 64 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2020 | 853 | 0.030 |
Why?
|
Cardiac Surgical Procedures | 1 | 2011 | 3537 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2862 | 0.030 |
Why?
|
Patient Care Management | 1 | 2019 | 306 | 0.030 |
Why?
|
Carotid Artery, Internal | 2 | 2002 | 445 | 0.030 |
Why?
|
Hemostatic Techniques | 1 | 1996 | 116 | 0.030 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 1995 | 92 | 0.030 |
Why?
|
Punctures | 1 | 1996 | 374 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2000 | 1240 | 0.030 |
Why?
|
Losartan | 1 | 2017 | 299 | 0.030 |
Why?
|
Depression | 1 | 2014 | 7760 | 0.030 |
Why?
|
Folic Acid | 1 | 2001 | 1293 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2015 | 162 | 0.030 |
Why?
|
Unemployment | 1 | 2016 | 214 | 0.030 |
Why?
|
Basilar Artery | 1 | 2015 | 200 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 3655 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2029 | 0.030 |
Why?
|
Hemostatics | 1 | 1996 | 229 | 0.030 |
Why?
|
Vibration | 1 | 2015 | 326 | 0.030 |
Why?
|
Regional Health Planning | 1 | 1994 | 97 | 0.030 |
Why?
|
Confidentiality | 1 | 2018 | 613 | 0.030 |
Why?
|
Behavior | 1 | 2016 | 559 | 0.030 |
Why?
|
Child | 4 | 2019 | 77637 | 0.030 |
Why?
|
Resuscitation | 1 | 2017 | 658 | 0.030 |
Why?
|
Hypertension, Renovascular | 2 | 2004 | 123 | 0.030 |
Why?
|
Anticholesteremic Agents | 1 | 2000 | 979 | 0.030 |
Why?
|
Choice Behavior | 1 | 1998 | 802 | 0.030 |
Why?
|
South Africa | 1 | 2018 | 1731 | 0.030 |
Why?
|
Weight Loss | 1 | 2024 | 2625 | 0.030 |
Why?
|
Cats | 1 | 2013 | 986 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2019 | 1263 | 0.030 |
Why?
|
Vascular Grafting | 1 | 2014 | 143 | 0.030 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2016 | 547 | 0.030 |
Why?
|
Boston | 2 | 2016 | 9310 | 0.030 |
Why?
|
Patient Transfer | 1 | 2019 | 762 | 0.030 |
Why?
|
Hearing Loss | 1 | 2019 | 765 | 0.030 |
Why?
|
Binomial Distribution | 1 | 1991 | 25 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2009 | 21733 | 0.030 |
Why?
|
Workplace | 1 | 2018 | 836 | 0.030 |
Why?
|
Whole Body Imaging | 1 | 2014 | 282 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 1995 | 1108 | 0.030 |
Why?
|
Preoperative Care | 3 | 2013 | 2251 | 0.020 |
Why?
|
Drug Combinations | 1 | 2017 | 1958 | 0.020 |
Why?
|
Nuclear Medicine | 1 | 2014 | 233 | 0.020 |
Why?
|
Peer Review, Research | 1 | 2014 | 329 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2018 | 25609 | 0.020 |
Why?
|
Waiting Lists | 1 | 2015 | 692 | 0.020 |
Why?
|
Fetal Organ Maturity | 1 | 1990 | 82 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2021 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2014 | 4848 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 824 | 0.020 |
Why?
|
Bibliometrics | 1 | 2014 | 338 | 0.020 |
Why?
|
Norway | 1 | 2011 | 448 | 0.020 |
Why?
|
Aspirin | 1 | 2002 | 3283 | 0.020 |
Why?
|
Early Detection of Cancer | 2 | 2014 | 3089 | 0.020 |
Why?
|
Myocardium | 1 | 2003 | 4775 | 0.020 |
Why?
|
Societies, Medical | 1 | 2002 | 3740 | 0.020 |
Why?
|
Endarterectomy | 1 | 2010 | 195 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2013 | 523 | 0.020 |
Why?
|
General Practice | 1 | 2011 | 100 | 0.020 |
Why?
|
Electronic Health Records | 2 | 2016 | 4467 | 0.020 |
Why?
|
Glomus Tumor | 1 | 1990 | 66 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29777 | 0.020 |
Why?
|
Barium Sulfate | 1 | 2009 | 180 | 0.020 |
Why?
|
Specialization | 1 | 2014 | 775 | 0.020 |
Why?
|
Sigmoidoscopy | 1 | 2009 | 156 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 3912 | 0.020 |
Why?
|
Physicians | 2 | 2018 | 4569 | 0.020 |
Why?
|
Internship and Residency | 1 | 2009 | 5787 | 0.020 |
Why?
|
Neoplasms | 2 | 2016 | 21675 | 0.020 |
Why?
|
Survivors | 2 | 2014 | 2291 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2001 | 3292 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2207 | 0.020 |
Why?
|
Adenosine | 1 | 2013 | 825 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4670 | 0.020 |
Why?
|
Health Expenditures | 1 | 2021 | 2348 | 0.020 |
Why?
|
Lacrimal Duct Obstruction | 1 | 1988 | 48 | 0.020 |
Why?
|
Colonography, Computed Tomographic | 1 | 2009 | 169 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2018 | 2265 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2001 | 3229 | 0.020 |
Why?
|
Collagen | 1 | 1996 | 2681 | 0.020 |
Why?
|
Renal Circulation | 1 | 2008 | 334 | 0.020 |
Why?
|
Data Collection | 1 | 1997 | 3339 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 1990 | 252 | 0.020 |
Why?
|
Laparoscopy | 2 | 2014 | 2148 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2007 | 229 | 0.020 |
Why?
|
Health Services Research | 1 | 1995 | 1836 | 0.020 |
Why?
|
Aortic Aneurysm | 1 | 1992 | 644 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2008 | 183 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2008 | 332 | 0.020 |
Why?
|
Fluorocarbons | 1 | 2011 | 452 | 0.020 |
Why?
|
Social Support | 1 | 2016 | 2118 | 0.020 |
Why?
|
Recurrence | 1 | 1998 | 8337 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2014 | 1928 | 0.020 |
Why?
|
Infant | 2 | 2018 | 35122 | 0.020 |
Why?
|
Family | 1 | 2016 | 3144 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3953 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 864 | 0.020 |
Why?
|
Wound Healing | 2 | 2006 | 2776 | 0.020 |
Why?
|
Rupture | 1 | 2006 | 433 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2004 | 193 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 2003 | 41 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3679 | 0.010 |
Why?
|
Internationality | 1 | 2010 | 1002 | 0.010 |
Why?
|
Morals | 1 | 2007 | 284 | 0.010 |
Why?
|
Dipyridamole | 1 | 2003 | 145 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2011 | 2307 | 0.010 |
Why?
|
Research | 2 | 2007 | 1999 | 0.010 |
Why?
|
Posture | 1 | 2008 | 957 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1996 | 1677 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6934 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2009 | 976 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2670 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1311 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 2008 | 782 | 0.010 |
Why?
|
Educational Measurement | 1 | 2009 | 1210 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1360 | 0.010 |
Why?
|
Gestational Age | 1 | 1990 | 3488 | 0.010 |
Why?
|
Primary Health Care | 1 | 1998 | 4556 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2003 | 585 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2010 | 2267 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 2003 | 535 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2008 | 2764 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2008 | 2924 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3574 | 0.010 |
Why?
|
Attention | 1 | 2009 | 2393 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5078 | 0.010 |
Why?
|
Population Surveillance | 1 | 2009 | 2614 | 0.010 |
Why?
|
History, 21st Century | 1 | 2004 | 1532 | 0.010 |
Why?
|
Pravastatin | 1 | 2000 | 395 | 0.010 |
Why?
|
Nerve Net | 1 | 2009 | 2173 | 0.010 |
Why?
|
Social Values | 1 | 1998 | 224 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7784 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2009 | 6976 | 0.010 |
Why?
|
Dopamine | 1 | 2003 | 1592 | 0.010 |
Why?
|
History, 20th Century | 1 | 2004 | 2736 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2009 | 4041 | 0.010 |
Why?
|
Health Policy | 1 | 2007 | 2662 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1990 | 4033 | 0.010 |
Why?
|
Brain Mapping | 1 | 2009 | 6622 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2001 | 1874 | 0.010 |
Why?
|
Aneurysm, False | 1 | 1996 | 276 | 0.010 |
Why?
|
Arteriovenous Fistula | 1 | 1996 | 315 | 0.010 |
Why?
|
Pressure | 1 | 1996 | 1205 | 0.010 |
Why?
|
Social Environment | 1 | 1998 | 1022 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1990 | 6363 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 6487 | 0.010 |
Why?
|
HIV Infections | 1 | 1998 | 16715 | 0.010 |
Why?
|
Safety | 1 | 1996 | 1184 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2001 | 2159 | 0.010 |
Why?
|
Hematoma | 1 | 1996 | 758 | 0.010 |
Why?
|
Arteries | 1 | 1996 | 1119 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168660 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 12954 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1996 | 1301 | 0.010 |
Why?
|
Obesity | 1 | 2009 | 12744 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1995 | 4370 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1992 | 12020 | 0.000 |
Why?
|